Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ
Dr. Joseph Merola

Dr. Joseph
Merola

Scientific Advisor

Dr. Joseph Merola

Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School

Dr. Merola is triple board certified in Dermatology, Internal Medicine, and Rheumatology. Dr. Merola is on the Medical Board of the National Psoriasis Foundation, the Board of the International Dermatology Outcome Measures Group, Steering Committee Member for GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), the Board of the Lupus Foundation of America and is on the Board and Founding President of the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN). Dr. Merola is also the president-elect of the Medical Dermatology Society. He is an active PI in several Psoriasis, Atopic Dermatitis and other leading skin indications.